We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Infusion Pump Market Worth $7 Billion in 2015

By HospiMedica International staff writers
Posted on 04 Jul 2016
The global market for infusion medical pumps grew at an average rate of 2.6% from $6.1 billion in 2010 to almost $7 billion in 2015. More...
These are the latest findings of Kalorama Information, (New York, NY, USA), an independent medical market research firm.

Infusion pumps are used to provide necessary fluids, basic fluids for hydration as well as pain medications, antibiotics, or chemotherapy, to a patient’s circulatory system. They are mostly used in emergency departments, operating rooms, and neonate departments of hospitals, long-term care settings, physician’s offices, and home settings when continuous monitoring and treatment is expensive, impractical, or unreliable.

Medical infusion pumps are divided in six categories, namely large volume infusion pumps, ambulatory infusion pumps, syringe infusion pumps, insulin infusion pumps, implantable infusion pumps, and enteral feeding pumps. Large volume infusion pumps are used for delivery of nutrients and hydration products to patients, while ambulatory infusion pumps are commonly used in hospital, surgical, home and emergency medical facilities. Syringe pumps are used for the delivery of precise amounts of fluid and drugs to patients, while insulin infusion pumps are employed for diabetes management in patients. Implantable infusion pumps are used for specific drugs, dosages, and routes of administration, while enteral feeding pumps are uses to provide liquid nutrition into the digestive system.

“Some areas of the market continue to display strong growth, including insulin infusion pumps and ambulatory enteral feeding pumps,” said Bruce Carlson, Publisher of Kalorama Information. “Each segments of the infusion pumps market has shown an increase, each segment experiencing a range of market drivers.”

“Smart” pump technologies and other advanced features have become a key driver of the infusion pump market. A smart pump is equipped with intravenous (IV) medication error-prevention software to alert operators when a pump setting is programmed outside of pre-configured limits. This, coupled with the growth in wireless capabilities, and advanced connectivity and integration is driving end users to evaluate device inventory and integrate advanced devices.

Some of the leading competitors and niche product developers include Baxter (Baxter, Deerfield, IL, USA), B. Braun (Melsungen, Germany), Halyard Health (Alpharetta, GA, USA), Johnson & Johnson (J&J, New Brunswick, NJ, USA), Medtronic (Dublin, Ireland), and Roche (Basel, Switzerland).

Related Links:
Kalorama Information
Baxter
Johnson & Johnson
Roche

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Pocket Fetal Doppler
CONTEC10C/CL
New
Cervical Seal
Omni Lok
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.